# Zotarolimus-Versus Sirolimus-Versus PacliTaxel-Eluting Stent for Acute Myocardial Infarction Patients

> **NCT00422565** · PHASE4 · TERMINATED · sponsor: **Seung-Jung Park** · enrollment: 328 (actual)

## Conditions studied

- Myocardial Infarction

## Interventions

- **DEVICE:** Endeavor, Medtronic
- **DEVICE:** Cypher, Cordis
- **DEVICE:** Taxus Liberte, Boston Scientific

## Key facts

- **NCT ID:** NCT00422565
- **Lead sponsor:** Seung-Jung Park
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-10
- **Primary completion:** 2008-09
- **Final completion:** 2008-09
- **Target enrollment:** 328 (ACTUAL)
- **Why stopped:** The recruitment rate was much slower than expected.
- **Last updated:** 2022-12-07

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00422565

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00422565, "Zotarolimus-Versus Sirolimus-Versus PacliTaxel-Eluting Stent for Acute Myocardial Infarction Patients". Retrieved via AI Analytics 2026-07-28 from https://api.ai-analytics.org/clinical/NCT00422565. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*